PROGETIS 500 INJ

Therapeutic information

Indications and uses

• Specialist obstetric use only where hydroxyprogesterone caproate remains locally authorised.
• Use only for the exact pregnancy-related indication stated in the current manufacturer-approved prescribing information.
• Use only after confirmation that the patient meets the authorised obstetric eligibility criteria.
• Use only after review of current national regulatory restrictions and pregnancy-safety information.
• Continuation only while the authorised regimen remains clinically appropriate under obstetric supervision.